Efficacy and safety of adalimumab among patients with moderate to severe psoriasis with co-morbidities: Subanalysis of results from a randomized, double-blind, placebo-controlled, phase III trial. (Q48744693)
Jump to navigation
Jump to search
scientific article published in February 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of adalimumab among patients with moderate to severe psoriasis with co-morbidities: Subanalysis of results from a randomized, double-blind, placebo-controlled, phase III trial. |
scientific article published in February 2011 |
Statements
1 reference
Efficacy and safety of adalimumab among patients with moderate to severe psoriasis with co-morbidities: Subanalysis of results from a randomized, double-blind, placebo-controlled, phase III trial. (English)
1 reference
Eric Q Wu
1 reference
Annie Guerin
1 reference
Alexa B Kimball
1 reference
Arielle G Bensimon
1 reference
Andrew P Yu
1 reference
Martin M Okun
1 reference
Yanjun Bao
1 reference
Shiraz R Gupta
1 reference
Parvez M Mulani
1 reference
1 February 2011
1 reference
12
1 reference
1
1 reference
51-62
1 reference
Identifiers
1 reference
1 reference